THE march of AI now seems unstoppable in every part of our lives, from choosing the TV we watch to making our trains run on ...
Last year, state epidemiologists studied an industrialized region east of Houston. They reported finding high rates of cancer ...
Explore the latest advancements in liquid biopsy for oncology, examining current trends and insights that could shape future ...
Having knowledge of the molecular characteristics of non-small cell lung cancer enhances understanding the disease, Dr. Fred R. Hirsch, Joe Lowe and Louis Price Professor of Medicine (Hematology and ...
Extensive Validation of BioMark’s Comprehensive Metabolic Panel in German 10,000-Participant HANSE Study, within the context of an international consortium supported under the EUREKA Network.
Invasive lung squamous cell carcinoma (LUSC) accounts for approximately one-quarter of all lung cancers, but therapeutic ...
The Independent on MSN
The health issues that could be an early sign of lung cancer
The health issues that could be an early sign of lung cancer - As the NHS offers a ‘revolutionary’ blood test, here are some ...
Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal Phase 3 IMforte trial Zepzelca and atezolizumab ...
Roche's Genentech received approval from the Food and Drug Administration for its drugs Tecentriq and Tecentriq Hybreza to be used in combination with lurbinectedin to treat lung cancer.
() - Small cell lung cancer (SCLC) is among the most aggressive, deadliest forms of lung cancer, yet it’s still too often ...
UD News The National Institutes of Health has awarded nearly a half-million dollars to two University of Dayton researchers ...
Air pollution is increasingly becoming a silent but deadly threat, particularly for urban non-smokers. Though active smoking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback